The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer-Reference-Cited by-同舟云学术

The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer

Published:2019-01-03 Issue:1 Volume:39 Page:1
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Guan Xiuwen¹,Ma Fei¹,Li Chunxiao²,Wu Shiyang³,Hu Shangying⁴,Huang Jiefen³,Sun Xiaoying⁵,Wang Jiayu¹,Luo Yang¹,Cai Ruigang¹,Fan Ying¹,Li Qiao¹,Chen Shanshan¹,Zhang Pin¹,Li Qing¹,Xu Binghe¹

Affiliation:

1. Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital; Chinese Academy of Medical Sciences and Peking Union Medical College; No. 17, Panjiayuan Nanli, Chaoyang District Beijing 100021 P. R. China

2. State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital; Chinese Academy of Medical Sciences and Peking Union Medical College; Beijing 100021 P. R. China

3. SurExam Bio-Tech; Guangzhou Technology Innovation Base, Science City; Guangzhou 510000 Guangdong P. R. China

4. Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital; Chinese Academy of Medical Sciences and Peking Union Medical College; Beijing 100021 P. R. China

5. Department of Medical Oncology; Huanxing Cancer Hospital; Beijing 100021 P. R. China

Funder

National Natural Science Foundation of China

National High Technology Research and Development Program of China

Major Project of Beijing Municipal Science and Technology Commission

CAMS Initiative for Innovative Medicine

PUMC Innovation Fund for Graduates

the Major Project of Beijing Municipal Science and Technology Commission

the CAMS Initiative for Innovative Medicine

Publisher

Wiley

Subject